Suivi biologique des patients vivant avec le VIH traités par anti-PD-1 ou anti-PD-L1 pour un cancer bronchique non à petites cellules : propositions d’un groupe de travail
Authors:
- 1 June 2016
- journal article
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 33 (6) , 419-421
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working GroupAnnals of Oncology, 2015
- Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinomaExperimental Hematology & Oncology, 2015
- Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV diseaseAIDS, 2014
- In Vivo Blockade of the PD-1 Receptor Suppresses HIV-1 Viral Loads and Improves CD4+ T Cell Levels in Humanized MiceThe Journal of Immunology, 2013
- Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer: Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort StudyJournal of Thoracic Oncology, 2011
- T cell exhaustionNature Immunology, 2011
- Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2008
- Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunctionNature Medicine, 2006
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 2006